Pharma Stocks

Follow pharmaceutical company stocks—blockbuster drugs, patent cliffs, pipeline depth, and pricing policy risks affecting pharma valuations.

Photo collage superimposing a Bristol Myers Squibb building facade on top of an AstraZeneca facade.
Stocks

Just call it BristolAstraMyersZenecaSquibb

But Wall Street isn't convinced it will work.

Sissy Yan
GLPs
Stocks

The $100 billion battle

Lucy Brewster
A split graphic of the Eli Lilly and Merck logos
Stocks

Big Pharma is making big moves

Big Pharma is hunting for its next blockbuster.

Lucy Brewster
Abbvie and Apogee logos superimposed on each other on a blue background.
Stocks

Big pharma is buying time

Abbvie's acquisition of Apogee is a sign of the times.

Lucy Brewster
Young female scientist conducting research in a lab
Stocks

Eli Lilly is vaccinating itself from competition

Lucy Brewster
A woman being treated for cancer
Stocks

Cancer care's next chapter

Big pharma is eyeing the future.

Sissy Yan
GLP-1 pen, tv dinner, bra
Stocks

Weight-loss drugs are changing everything

Judy Dutton

Making sense of market moves

Stay up to date on the latest market news with daily analysis of the investing landscape, served up Brew-style.

By subscribing, you accept our Terms & Privacy Policy.

A mobile phone scrolling a newsletter issue of Brew Markets